Inferring the temporal order of cancer gene mutations in individual tumor samples.

Identification of neutral tumor evolution across cancer types. Nat Genet (2016) 1.25

A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population. PLoS One (2014) 0.75

Hallmarks of cancer: the next generation. Cell (2011) 140.01

The hallmarks of cancer. Cell (2000) 113.05

A genetic model for colorectal tumorigenesis. Cell (1990) 44.37

Surfing the p53 network. Nature (2000) 35.36

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Lessons from hereditary colorectal cancer. Cell (1996) 25.73

Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76

Cancer genes and the pathways they control. Nat Med (2004) 24.22

Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68

Uncovering the overlapping community structure of complex networks in nature and society. Nature (2005) 13.05

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer (2004) 12.35

An oncogene-induced DNA damage model for cancer development. Science (2008) 11.60

The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene (2007) 10.08

MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52

Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39

Link communities reveal multiscale complexity in networks. Nature (2010) 5.48

COSMIC 2005. Br J Cancer (2006) 5.07

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood (2005) 3.45

Network link prediction by global silencing of indirect correlations. Nat Biotechnol (2013) 3.27

Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A (1996) 2.75

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood (2010) 2.61

Homologous recombination and its regulation. Nucleic Acids Res (2012) 2.44

Network deconvolution as a general method to distinguish direct dependencies in networks. Nat Biotechnol (2013) 2.05

Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov (2012) 2.01

Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res (2010) 1.82

A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci U S A (2010) 1.81

Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target? Clin Cancer Res (2011) 1.21

Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) (2011) 1.21

The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One (2011) 1.20

Regulation of caspase expression and apoptosis by adenomatous polyposis coli. Cancer Res (2003) 1.11

APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg (2005) 1.03

Mutual repression by bantam miRNA and Capicua links the EGFR/MAPK and Hippo pathways in growth control. Curr Biol (2012) 0.98

Tumor progression: a brief historical perspective. Semin Cancer Biol (2002) 0.97

RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability. Neuro Oncol (2011) 0.82

An activation force-based affinity measure for analyzing complex networks. Sci Rep (2011) 0.79

JAK2V⁶¹⁷F/TET2 mutations: does the order matter? Haematologica (2011) 0.77